490 Results (Page 11 of 20)
Canada Markets Research Reports
Canada Topical Drugs Delivery Market Analysis
Canada Topical Drugs Delivery Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Topical drugs delivery market is growing globally due to the rising incidence and prevalence of various skin disorders, such as acne, eczema, psoriasis, and dermatitis, advancements in formulation technologies like nano emulsions, liposomes, micelles, and transdermal patches, patient preference for non-invasive treatment that minimize side effects and offer localized therapy, growing aging population, rising demand for dermatological cosmetics due to focus on personal grooming, increased research and development activities and favorable regulatory environments. Johnson & Johnson Private Limited, Nestlé India Ltd., Novartis AG, GlaxoSmithKline plc, Bausch Health Companies Inc., Merck & Co Inc., Bayer AG, Hisamitsu Pharmaceutical Co.,Inc., Glenmark Pharmaceuticals Limited are the key global market players in topical drugs delivery market.
Canada Topical Pain Relief Market Analysis
Canada Topical Pain Relief Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Topical Pain Relief market is growing globally due to the increase in incidence and prevalence of Chronic pain conditions such as arthritis, back pain, and musculoskeletal disorders, growing preference for non-opioid pain management due to addictive nature of opioid medications, ease of use and convenience of topical pain relief products, expanding product range and innovation, Increasing Consumer Awareness, Over-the-Counter Availability and rising healthcare expenditure. Advacare Pharma, GlaxoSmithKline Plc (GSK), Johnson & Johnson, Nestlé S.A., Novartis AG, Pfizer Inc., Reckitt Benckiser Group Plc., Sanofi, Sun Pharmaceutical Industries Ltd are the key global market players in topical pain relief market.
Canada Transdermal Skin Patches Market Analysis
Canada Transdermal Skin Patches Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Transdermal Skin Patches market is growing globally due to the increasing demand for non-invasive drug delivery, growing prevalence of chronic diseases like cardiovascular disorders, pain management, hormonal imbalances and neurological conditions, geriatric application and pediatric applications of transdermal skin patches due to better patient compliance, advancements in patch technology, expansion of therapeutic applications of transdermal skin patches like hormone replacement therapy, smoking cessation, motion sickness, dermatological conditions, and increasing focus on personalized medicine. Adhex Pharma, ProSolus, Inc, Tapemark, Tesa Tapes Pvt. Ltd., Nitto Denko Corporation, Noven Pharmaceuticals, Inc, LTS Lohmann Therapie-Systeme are the key global market players in transdermal skin patches market.
Canada Transthyretin Amyloidosis (ATTR) Market Analysis
Canada Transthyretin Amyloidosis (ATTR) Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Transthyretin Amyloidosis (ATTR) market is growing globally due to the increase in disease awareness, advancements in diagnostic techniques, development of disease-modifying therapies, growing investment in research and development, regulatory support and expedited approvals, collaboration and partnerships between pharmaceutical companies and academic institutions. Pfizer Inc, AstraZeneca, Prothena Corporation plc, Ionis Pharmaceuticals, BELLUS Health Inc , Alnylam Pharmaceuticals, Inc, Eidos Therapeutics, Inc, SOM BIOTECH, Abbvie, Inc., Bausch Health Companies Inc., Bristol Myers Squibb Company, GSK Plc. are the key global market players in transthyretin amyloidosis (ATTR) market.
Canada Type 1 Diabetes Mellitus Drugs Market Analysis
Canada Type 1 Diabetes Mellitus Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Type 1 Diabetes Mellitus Drugs market is growing globally due to the rising prevalence of type 1 diabetes mellitus, advancements in insulin therapies, technological advancements in insulin delivery systems, increasing focus on personalized medicine, rising healthcare expenditure, favorable reimbursement policies, increasing patient awareness and education, research and development initiatives and collaborations between pharmaceutical companies and academic institutions. Novo Nordisk, Eli Lilly and Company, Sanofi, Medtronic, Abbott Laboratories, Dexcom, Zealand Pharma, Xeris Pharmaceuticals, Insulet Corporation, and Tandem Diabetes Care are the key global market players in type 1 diabetes mellitus drugs market.
Canada Type 2 Diabetes Mellitus Drugs Market Analysis
Canada Type 2 Diabetes Mellitus Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Type 2 Diabetes Mellitus Drugs market is growing globally due to the increasing prevalence of Type 2 diabetes, growing awareness and diagnosis about the disease, advancements in drug therapies, rising geriatric population, government initiatives and healthcare policies, technological advancements in drug delivery, increasing research and development activities and rising healthcare infrastructure. Novo Nordisk, Sanofi, Eli Lilly and Company, Merck & Co., Inc., AstraZeneca, Johnson & Johnson, Boehringer Ingelheim, Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb, Novartis International are the key global market players in type 2 Diabetes Mellitus Drugs Market.
Canada Tyrosine Kinase Inhibitors Market Analysis
Canada Tyrosine Kinase Inhibitors Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Tyrosine Kinase Inhibitors market is growing globally due to the Increasing prevalence of cancer, increasing use instead of conventional medicines due to their benefits, including the simplicity of oral administration, the capacity to target various cellular survival pathways, and the surge in demand for novel medications. The market is also influenced by an increase in pharmaceutical company investment and the utilization of cell processes to control different cell activities in cancer. Additionally, the market for tyrosine kinase inhibitors is positively impacted by increase in healthcare spending, awareness, population growth, increased healthcare infrastructure, and improvements in cancer treatments. F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Ascentage Pharma, AstraZeneca, Eisai Co., Ltd., Novartis AG, Sanofi, Bristol-Myers Squibb Company, Genentech, Inc., Pfizer Inc., Merck & Co., Inc., Suzhou Zelgen Biopharmaceuticals Co., Ltd., Celldex Therapeutics, Exelixis, Inc., Sino Biological Inc., AB Science, Bayer AG Deciphera Pharmaceuticals, Inc., and Johnson & Johnson Services, Inc are the key global market players in tyrosine kinase inhibitors market.
Canada Ulcerative Colitis Market Analysis
Canada Ulcerative Colitis Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Ulcerative Colitis market is growing globally due to the increasing prevalence of ulcerative colitis, advancements in treatment options like introduction of biologic therapies, such as anti-TNF agents, anti-integrin agents and JAK inhibitors, rising awareness and diagnosis about disease, personalized medicine approaches, research and development initiatives, collaborations and partnerships between pharmaceutical companies and academic institutions. Johnson and Johnson, AbbVie Inc. (Allergan, Inc.), Merck & Co., Inc., Novartis AG, Bausch Health Companies Inc. are the key global market players in ulcerative colitis market.
Canada Unresectable Hepatocellular Carcinoma Market Analysis
Canada Unresectable Hepatocellular Carcinoma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Unresectable Hepatocellular Carcinoma market is growing globally due to the increasing incidence of unresectable hepatocellular carcinoma which is mainly due to rise in risk factors such as chronic hepatitis B and C infections, alcohol abuse, non-alcoholic fatty liver disease (NAFLD), and obesity. Advancements in diagnostic techniques like imaging techniques and biopsy, introduction of targeted therapies, immunotherapies, rising emphasis on combination therapies, clinical Trials and research initiatives. Bayer AG, Bristol Myers Squibb Company, Eisai Co., Ltd., Exelixis, Inc., Ipsen Pharma, Merck & Co., Inc., Novartis International AG, Roche Holding AG, Sanofi S.A., Takeda Pharmaceutical Company Limited are the key global market players in unresectable hepatocellular carcinoma market.
Canada Urothelial Carcinoma Market Analysis
Canada Urothelial Carcinoma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Urothelial Carcinoma market is growing globally due to the increasing incidence and prevalence of urothelial carcinoma due to aging population, smoking, exposure to certain chemicals, and chronic bladder inflammation, advancements in diagnostic techniques like urinary biomarkers, cystoscopy, development of novel therapies like targeted therapies or immune checkpoint inhibitors and increased focus on personalized medicine. AstraZeneca PLC, Bristol Myers Squibb Company, Eli Lilly and Company, Genentech, Inc. (a member of the Roche Group), Merck & Co., Inc., Novartis AG, Pfizer Inc., Seattle Genetics, Inc., Sanofi S.A., Johnson & Johnson are the key global market players in urothelial carcinoma market.
Canada Varicella Vaccine Market Analysis
Canada Varicella Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Varicella Vaccine market is growing globally due to the increasing vaccination coverage, growing public awareness about varicella vaccination, well established safety and efficacy profile of varicella vaccine, launch of varicella control programs by various governments. Merck & Co., Inc., GlaxoSmithKline plc, Sanofi Pasteur, Pfizer Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech International Ltd., Changchun BCHT Biotechnology Co., Ltd., Sinovac Biotech Ltd., Kaketsuken (Japan Blood Products Organization) and Shanghai Institute of Biological Products are the key global market players.
Canada Viscosupplementation Market Analysis
Canada Viscosupplementation Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Viscosupplementation market is growing globally due to the increasing prevalence of osteoarthritis, growing aging population, and rising awareness about minimally invasive treatment options, increasing awareness and acceptance, technological advancements in viscosupplementation treatments, rise in the healthcare sector spending and infrastructure. Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, Bioventus, Fidia Farmaceutici S.P.A, Ferring B.V, sanofi-aventis U.S. LLC, Zimmer Biomet, OrthogenRx, Inc. (a subsidiary of AVNS), APTISSEN, Johnson & Johnson Services, Inc., LG Chem., Viatris Inc., IBSA Institut Biochimique SA, Ortobrand International, TRB CHEMEDICA SA, Teva Pharmaceutical Industries Ltd., Lifecore (a subsidiary of Landec Corporation), VIRCHOW are the key global market players of viscosupplementation market.
Canada Vision Care Market Analysis
Canada Vision Care Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Vision Care market is growing globally due to the increasing prevalence of eye disorders such as myopia, hyperopia, astigmatism, and age-related macular degeneration (AMD), surging volume of patients suffering from chronic diseases which will led to the occurrences of vision ailments, improper intake of nutrition and unhealthy food eating habits, technological advancements in vision care industry like innovations in lens materials, frame designs, and contact lens technologies, increasing awareness about the importance of regular eye exams and eye health initiatives by governments, healthcare organizations and growth of the e-commerce sector. EssilorLuxottica, Johnson & Johnson, Novartis AG (Alcon), CooperVision, Bausch Health Companies (Bausch + Lomb), Zeiss, Hoya Corporation, Safilo Group and Carl Zeiss Meditec are the key global market players.
Canada Wearable Injectors Market Analysis
Canada Wearable Injectors Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Wearable Injectors market is growing globally due to the strong healthcare infrastructure, rise in the incidence of lifestyle disorders, an ageing population that is more susceptible to diseases, increase in the desire for minimally invasive (MI) treatment alternatives, rise in chronic diseases like diabetes, autoimmune diseases, patient preference for self-administration medications in the comfort of their homes which enhances patient convenience, improves medication adherence, technological advancements in wearable injector technology which have improved device usability, functionality, patient experience. Continuous drug delivery provided by wearable injectors like more stable drug levels, reduced fluctuations, focus on patient centric care and cost-effective solutions provided by wearable injectors. Medtronic plc, Insulet Corporation, West Pharmaceutical Services, Inc., Enable Injections, SteadyMed Therapeutics, Inc., Sensile Medical AG, CeQur SA, Ypsomed AG, Becton, Dickinson and Company and Tandem Diabetes Care, Inc. are the key global market players in wearable injectors market.
Canada Asthma and COPD Therapeutics Market Analysis
The Canada Asthma and COPD Therapeutics Market was valued at US $2.67 Bn in 2022, and is predicted to grow at (CAGR) of 5.20% from 2023 to 2030, to US $4.00 Bn by 2030. The key drivers of this industry include the upward trend in the prevalence of COPD and asthma, the adverse effects of COVID-19, rising healthcare expenses, and others. The industry is primarily dominated by players such as AstraZeneca, Abbott, GSK, Novartis Pfizer, and Boehringer Ingelheim, among others.
Canada Anemia Therapeutics Market Analysis
The Canada Anemia Therapeutics Market is anticipated to experience a growth from $1.184 Bn in 2022 to $2.377 Bn by 2030, with a CAGR of 9.1% during the forecast period of 2022-2030. The market driver for Canada Anemia Therapeutics Market is propelled by the increasing prevalence of anemia among the aging population, driven by chronic diseases and nutritional deficits, coupled with the growing burden of non-communicable diseases like Chronic Kidney Disease (CKD) and cancer, creating a significant and expanding patient pool. The Canada Anemia Therapeutics Market encompasses various players across different segments, including Amgen, Roche, Takeda Pharmaceutical, Sanofi, Novartis, Apotex, Pharmascience, Biovail, Paladin Labs, Aurin Pharmaceuticals, etc, among various others.
Canada Antibacterial (Antibiotics) Drugs Market Analysis
Canada Antibacterial (Antibiotics) Drugs Market is at around $4.07 Bn in 2023 and is projected to reach $5.4 Bn in 2030, exhibiting a CAGR of 4.2% during the forecast period. The market is being driven by factors such as the rise in infectious disease incidence, the expansion of healthcare infrastructure, and the increase in awareness and education. The market is dominated by key players like Pfizer Canada, GlaxoSmithKline (GSK), Johnson & Johnson Inc. (J&J), Merck Canada, Abbott Laboratories Limited, Astra Zeneca Canada, Sanofi Canada, Novartis Pharmaceuticals Canada Inc., Eli Lilly Canada Inc., and F. Hoffmann-La Roche Ltd.
Canada Cardiovascular Drugs Market Analysis
Canada Cardiovascular Drug Market is at around $11.1 Bn in 2022 and is projected to reach $14.91 Bn in 2030, exhibiting a CAGR of 3.8% during the forecast period. One major factor propelling the market’s expansion is personalized medicine. It utilizes a patient's genetic and molecular profile to customize treatment. The market is dominated by key players like Bristol-Myers Squibb Canada Co, Pfizer Canada, Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca Canada Inc., Sanofi-Aventis Canada Inc., Novartis Pharmaceuticals Canada, Merck & Co., Inc., Gilead Sciences Canada, Inc., and F. Hoffman-La Roche Ltd.
Canada Alopecia (Hair Loss) Therapeutics Market Analysis
The Canada Alopecia (Hair Loss) Therapeutics Market was valued at US $0.65 Bn in 2022, and is predicted to grow at (CAGR) of 7.50% from 2023 to 2030, to US $1.17 Bn by 2030. The key drivers of this industry include the upward trend in the prevalence of Alopecia (hair loss), improved treatment options. The industry is primarily dominated by players such as Eli Lilly, Pfizer, Allergan, Valeant, Bayer, Roche, AbbVie among others.
Canada Digital Therapeutics Market Analysis
Canada Digital Therapeutics Market is at around $0.5 Bn in 2023 and is projected to reach $2.7 Bn in 2030, exhibiting a CAGR of 27.2% during the forecast period. The industry is being driven by advancements in technology, government support and regulations, and growing awareness. The market is dominated by key players like Omada Health Inc., WellDoc Inc., 2Morrow Inc., Livongo Health Inc., Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., HYGIEIA, BigHealth, and Voluntis.
Canada Allergy Therapeutics Market Analysis
Canada Allergy Therapeutics Market was valued at $1856 Mn in 2022 and is estimated to reach $3049 Mn in 2030, exhibiting a CAGR of 6.4% during the forecast period. The rising incidence of allergic diseases and associated illnesses is a major market driver for the expansion of the allergy therapeutics market. Some of the leading pharmaceutical companies operating in the market are Sanofi, Novartis, GlaxoSmithKline (GSK), AstraZeneca, Merck & Co., Johnson & Johnson, Roche, Teva Pharmaceutical Industries, ALK-Abelló, and Stallergenes Greer
Canada Age-Related Macular Degeneration Therapeutics Market Analysis
The Canada Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $0.86 Bn in 2022, and is predicted to grow at a CAGR of 8.9% from 2023 to 2030, to US $1.71 Bn by 2030. The key drivers of this industry include the upward trend in the prevalence of age-related macular degeneration, advancements in diagnostic technologies, and other factors. The industry is primarily dominated by players such as Genentech, Novartis, Bayer, Roche, and Ocular Therapeutics, among others
Canada Alcohol Addiction Therapeutics Market Analysis
The Canada Alcohol Addiction Therapeutics Market is valued at around $57 Mn in 2022 and is projected to reach $93 Mn by 2030, exhibiting a CAGR of 6.3% during the forecast period. The Increasing public awareness, government support, and advancements in research and innovation are driving the destigmatization of alcohol addiction, fostering greater acceptance of mental health, and fueling the demand for more accessible and personalized treatment options, thus increasing market growth. The key players involved in the research, development, and distribution of alcohol addiction therapeutics in Canada are AbbVie, AstraZeneca, Roche, Bausch Health, Pfizer, Otsuka, Alkermes, Ethypharm, Biovail, Beacon etc among others.
Canada Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis
The Canada Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $264 Mn in 2022 and is predicted to grow at a CAGR of 7.8% from 2023 to 2030, to US $481 Mn by 2030. The key drivers of this industry include the upward trend in the incidence of acute lymphocytic leukaemia cases, advancements in molecular biology and pharmacology technologies, and other factors. The industry is primarily dominated by players such as Pfizer, Sanofi, Novartis, Genmab among others.
Canada Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis
The Canada Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US $88 Mn in 2022, and is predicted to grow at (CAGR) of 5.8% from 2023 to 2030, to US $138 Mn by 2030. The key drivers of this industry include the upward trend in the incidence of autosomal dominant polycystic kidney disease, the aging population, novel therapeutics, and other factors. The industry is primarily dominated by players such as Pfizer, Sanofi, Novartis, and Teva Pharmaceutical, among others